Javier Marquez PhD

Javier Marquez is the deputy scientific director of the IBIMA Plataforma BIONAND Institute and lead researcher of Group B-07: “Canceromics” at the Institute. Dr. Márquez is a full professor of biochemistry and molecular biology at the University of Málaga and scientific manager of the Proteomics Research Support Services since 2007. He completed a two-year postdoctoral fellowship at the University of Missouri - Kansas City in the United States of America from 1987 to 1989 and was a visiting professor at Brandeis University in Boston, United States of America, at Harvard Medical School in Cambridge, United States of America, and the Medical University of Vienna, Austria. He is the author of more than 110 scientific publications in international peer-reviewed, indexed journals with more than 5,200 citations and an h-index of 41. He is the principal investigator on more than 25 national and international competitive public projects.

Other indicators of the quality of his scientific production include six uninterrupted six-year terms in research since 1984, one six-year term in transfer, and 14 doctoral theses directed. He is a member of the editorial review boards for the journals Frontiers in Molecular Neuroscience and CANCERS. As part of his teaching work, he has taught courses on biochemistry and molecular biology at the UMA Faculty of Sciences for biology, environmental sciences, chemistry, and biochemistry undergraduate degrees since 1988. Furthermore, he has participated in numerous doctoral programs at the UMA and the International University of Andalusia (UNIA, for its initials in Spanish). He currently serves as coordinator for a course in the Master’s Degree in Advanced Biotechnology at the UMA.

Notable among his research evaluation work is his role as an expert assessor for the Life Sciences speech for the European Union’s Marie Skłodowska-Curie Actions, Horizon 2020, and Horizon Europe excellence programs since 2003. He is an assessor for research projects for the Ministry of Education, the Ministry of Science and Innovation, and the National Agency for Evaluation and Futurology (ANEP, for its initials in Spanish). He is a member of the review board for Ramón y Cajal postdoctoral contracts in biomedicine, an assessor for research projects and grants for the Board of Life Sciences of the Andalusia Regional Government, and an expert assessor for the National Agency for Scientific and Technological Promotion of Argentina, the Fund for Scientific and Technological Research (FONCYT, for its initials in Spanish), and the National Science Centre of Krakow, Poland